Any acquisition of Theranos will be after the book is closed and the assets are sold off. People working there will likely have a big hole in their resume's that they'd rather not talk about.
https://twitter.com/JohnCarreyrou/status/877499269191782402
>Theranos burning $10 mln a month, will have less than $30 mln left after Walgreens settlement. You do the math...
Liquidating office equipment:
Where's the line on this? Is Enron a hole on the resume? How about Arthur Andersen? Do companies like Uber make the mix?
There is no indication of this. Why would you suggest that a proven and humiliated scam company has these capabilities?
Theranos raised $750 million, including $633 million last year.
* Social Network: Theranos raised money from a wide range of influential investors who can support the company's efforts to secure new customers and who stand to lose to varying degrees if instead Theranos completely folds, even if it returns the remaining balance of funds raised.
* Core organizational processes: the company still has hundreds of employees on the payroll, most of whom are qualified professionals in this field. It is not trivial to recruit and bring together an organization like that. It's unlikely that most of those hundreds of people were directly involved in the shenanigans of the company.
I think those are 3 assets the company would use towards a pivot like I described. But you can't do it without removing the leader who got them here.
A material handling robot, a camera, a centrifuge, a cytometer, etc etc.... it's like a really neat Swiss army toy that would probably be great in the hands of researchers, provided that this hardware has a somewhat open API. Presuming that it more or less works, it's kind of cool, and lots of labs (both proper medical and research labs) would probably be interested in buying such a thing and would gladly pay a good few thousand bucks for it.
A minilab will cost way more than that...just the centrifuge component cost is in the thousands. A lab already has this type of equipment...the expected use is for point of care...but which doctor's office will want to spend $50k++ (plus ongoing reagent costs etc.) for results that will be less accurate than from a regular lab? So maybe military usage? In any case, they have not released any update at all on it for a year.
And yes, these doctors would order absolutely everything they can bill for as it was going in their pocket. Homocystine, and Vitamin D are 2 high reimbursement tests they liked a lot.
However as I always said about Theranos they have no technology that could possibly work for a wide variety of analytes, and this is already a very competitive market in both equipment and labs. They still don't have a chance. I have no idea how people were so fooled by this. A 40+ billion dollar long existing industry that relies on heavily regulated hard science is not going to be disrupted by a college dropout.
Nobody will ever buy anything from them. Nobody should.
> Nobody will ever buy anything from them. Nobody should.
Oh, trust me, a lot of people will buy things like minilab if it's marketed well, there's a lot of money for these things. A common price for any medical research hardware of the serious kind is tens of thousands (my lab got a confocal microscope only recently for $200k; our sister lab bought a diamond turning machine for about 2 million to create glass lens).
But they've been at this since 2003 and have pages of patents, http://patents.justia.com/assignee/theranos-inc
It'd be surprising if there was nothing of value.
They got here through hype, smoke and mirrors, but they now have the capital, social network and core organizational processes in place to do this and it is a rational path to recouping time and $ investments from everyone involved.
However it will be difficult/impossible for this to pivot to happen without Elizabeth Holmes' resignation.